e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smoking and carotid atherosclerosis
Z. Arsovski, B. Kaeva, M. Gavrilovski, Z. Goseva, S. Pejkovska, S. Arbutina, F. Demiri (Skopje, Fyrom)
Source:
Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Session:
Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Session type:
E-Communication Session
Number:
2059
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Arsovski, B. Kaeva, M. Gavrilovski, Z. Goseva, S. Pejkovska, S. Arbutina, F. Demiri (Skopje, Fyrom). Smoking and carotid atherosclerosis. Eur Respir J 2010; 36: Suppl. 54, 2059
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lung ultrasound
Pleural ultrasound
Group assignment
Related content which might interest you:
Carotid atherosclerosis in COPD patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
OSA and coronary artery disease
Source: Sleep and Breathing Conference 2021
Year: 2021
The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
COPD as a risk factor for carotid artery disease (CAD) and low-extremity artery disease (LEAD)
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Lower extremity and carotid artery disease in COPD
Source: ERJ Open Res, 2 (4) 00037-2016; 10.1183/23120541.00037-2016
Year: 2016
Pulmonary arterial hypertension and coronary artery stenosis in neurofibromatosis
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001
Remodeling of common carotid and common femoral arteries in COPD patients without previously diagnosed cardiovascular diseases (CVD).
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013
Pulmonary artery aneurysms in Behçet disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Analysis of atherosclerosis in patients with chronic obstructive pulmonary disease by carotid ultrasonography
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Coronary artery calcification in COPD is associated with adverse functional assessments and mortality
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Is intracardiac thrombus a risk factor for the development of pulmonary artery aneurysm in behcet disease?
Source: Eur Respir J 2002; 20: Suppl. 38, 63s
Year: 2002
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Carotid wall intima-media thickness (IMT) in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Dyspnea in patients with coronary artery disease: is it related with physiologic measurements?
Source: Eur Respir J 2001; 18: Suppl. 33, 300s
Year: 2001
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Association between centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept